| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2012 | US8227492 Sulfoxamine derivatives as factor Xa inhibitors |
| 07/24/2012 | US8227491 5-(3,4-dichloro-phenyl)-N-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide and salts thereof |
| 07/24/2012 | US8227490 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
| 07/24/2012 | US8227489 N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 07/24/2012 | US8227488 Injectable depot formulation comprising crystals of iloperidone |
| 07/24/2012 | US8227487 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 07/24/2012 | US8227486 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 07/24/2012 | US8227485 Benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 07/24/2012 | US8227484 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 07/24/2012 | US8227483 Polymorphs of 6-beta-naltrexol |
| 07/24/2012 | US8227482 Forms of rifaximin and uses thereof |
| 07/24/2012 | US8227481 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof |
| 07/24/2012 | US8227480 Indazole derivative having spiro ring structure in side chain |
| 07/24/2012 | US8227479 DHA esters and use thereof in treatment and prevention of cardiovascular disease |
| 07/24/2012 | US8227478 JNK modulators |
| 07/24/2012 | US8227477 Nilotinib HCl crystalline forms |
| 07/24/2012 | US8227476 Using 1-(2-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)-2,3-dihydro-1h-benzimidazol-2-one |
| 07/24/2012 | US8227475 Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide |
| 07/24/2012 | US8227474 Sodium channel blockers |
| 07/24/2012 | US8227473 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| 07/24/2012 | US8227472 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 07/24/2012 | US8227471 Treating sexual desire disorders with flibanserin |
| 07/24/2012 | US8227470 Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors |
| 07/24/2012 | US8227469 Vanilloid receptor ligands and their use in treatments |
| 07/24/2012 | US8227468 Cathepsin S inhibitor compounds |
| 07/24/2012 | US8227467 Therapeutic agents useful for treating pain |
| 07/24/2012 | US8227466 Prostaglandin transporter inhibitors |
| 07/24/2012 | US8227464 Substituted oxazolidinone derivatives |
| 07/24/2012 | US8227463 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 07/24/2012 | US8227462 Pyrrolidine-1,2-dicarboxamide derivatives |
| 07/24/2012 | US8227461 Isoxazoles |
| 07/24/2012 | US8227460 Methylene blue |
| 07/24/2012 | US8227459 Diamino-phenothiazinyl derivatives as antiviral treatments |
| 07/24/2012 | US8227458 Arylcyclohexylethers of dihydrotetraazabenzoazulenes |
| 07/24/2012 | US8227457 Method for treatment of diseases |
| 07/24/2012 | US8227456 Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives |
| 07/24/2012 | US8227455 Methods of treating cell proliferative disorders |
| 07/24/2012 | US8227454 Estrogenic compounds, pharmaceutical compositions and formulations comprising the same |
| 07/24/2012 | US8227453 Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
| 07/24/2012 | US8227452 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 07/24/2012 | US8227451 Phenylacetic acid inhibitors of cyclooxygenase |
| 07/24/2012 | US8227450 Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
| 07/24/2012 | US8227449 Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation |
| 07/24/2012 | US8227448 Nutritional composition with health promoting action containing oligosaccharides |
| 07/24/2012 | US8227446 Oligodeoxynucleotide and its use to induce an immune response |
| 07/24/2012 | US8227445 Methods of treating hypertension |
| 07/24/2012 | US8227443 Silencing of CSN5 gene expression using interfering RNA |
| 07/24/2012 | US8227441 Methods to increase or decrease bone density |
| 07/24/2012 | US8227438 Suppressors of CpG oligonucleotides and methods of use |
| 07/24/2012 | US8227434 Materials and methods for treating oncological disorders |
| 07/24/2012 | US8227433 Use of inhibitors and antisense oligonucleotides of BTK for treating proliferative mastocytosis |
| 07/24/2012 | US8227431 Nucleoside derivatives |
| 07/24/2012 | US8227430 Injectable, injection solution, and injection kit preparation |
| 07/24/2012 | US8227429 Macrolide synthesis process and solid-state forms |
| 07/24/2012 | US8227428 Anti-infammatory macrolide |
| 07/24/2012 | US8227427 Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectin and/or milbemycin |
| 07/24/2012 | US8227425 Antiviral compounds |
| 07/24/2012 | US8227404 Method of preventing acute or sub-acute hepatic failure in a subject by administering a soluble human tumor necrosis factor alpha fusion protein |
| 07/24/2012 | US8227401 Optically active muscone composition and fragrances or cosmetics containing the same |
| 07/24/2012 | US8227200 Methods for identifying kremen polypeptide binding partners |
| 07/24/2012 | US8227027 Method for applying a polymer coating to an internal surface of a container |
| 07/24/2012 | US8226994 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques |
| 07/24/2012 | US8226982 Inhalable powders comprising protein, phenylalanine, and other protein stabilizers |
| 07/24/2012 | US8226981 Method of preparing a taste-masking oral dosage form |
| 07/24/2012 | US8226979 Drug coating providing high drug loading and methods for providing the same |
| 07/24/2012 | US8226977 Pharmaceutical composition containing irbesartan |
| 07/24/2012 | US8226974 Backing layer impermeable to nicotine, of a nicotine containing intermediate matrix layer immediately adjacent to the backing layer, of another nicotine-containing matrix layer, and of a peelable protective layer, wherein the matrix |
| 07/24/2012 | US8226973 Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use |
| 07/24/2012 | US8226972 Vaginal delivery of drugs |
| 07/24/2012 | US8226957 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences |
| 07/24/2012 | CA2746682A1 Process for the preparation of antibiotic compounds |
| 07/24/2012 | CA2699454C Methods for inhibiting tgf-.beta. |
| 07/24/2012 | CA2690483C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 07/24/2012 | CA2690226C Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 07/24/2012 | CA2686378C Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 07/24/2012 | CA2663044C Quinolone carboxylic acids, derivatives thereof, and methods of making and using same |
| 07/24/2012 | CA2651193C High concentration topical insecticides containing pyrethroids |
| 07/24/2012 | CA2637672C Sublingual fentanyl spray |
| 07/24/2012 | CA2622713C Anthelmintic formulations |
| 07/24/2012 | CA2605923C Use of antagonists of oxytocin and/or vasopressin |
| 07/24/2012 | CA2566687C The use of tiacumicin b in the treatment of antibiotic resistant staphylococcus or vancomycin-resistant enterococci infections |
| 07/24/2012 | CA2564887C The use of timosaponin bii for preparing a drug for preventing or treating stroke |
| 07/24/2012 | CA2547625C Crystals of phenylalanine derivatives and production methods thereof |
| 07/24/2012 | CA2540102C A combination of candesartan and rosuvastatin for the treatment of atherosclerosis |
| 07/24/2012 | CA2536482C Penetrating pharmaceutical foam |
| 07/24/2012 | CA2535724C Compositions containing topical active agents and pentylene glycol |
| 07/24/2012 | CA2527435C Amino acid composition and supplementary liquid containing the same |
| 07/24/2012 | CA2526082C Triazole-derivatives as factor xa inhibitors |
| 07/24/2012 | CA2517427C Antiprotozoal imidazopyridine compounds |
| 07/24/2012 | CA2488167C Prodrugs of excitatory amino acids |
| 07/24/2012 | CA2486252C Methods for screening for agents that modulate hepatocellular carcinoma development |
| 07/24/2012 | CA2477053C Composition for easing human childbirth |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/24/2012 | CA2474243C Medical device for delivering biologically active material |
| 07/24/2012 | CA2473700C Method for stabilizing reduced coenzyme q10 and composition therefor |
| 07/24/2012 | CA2458146C Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 07/24/2012 | CA2455039C Reduction of hair growth |
| 07/24/2012 | CA2444108C Nociceptin analogs |
| 07/24/2012 | CA2412172C 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 07/24/2012 | CA2386716C Magnesium salt of s-omeprazole |